Literature DB >> 22511790

Inactivation of Pink1 gene in vivo sensitizes dopamine-producing neurons to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and can be rescued by autosomal recessive Parkinson disease genes, Parkin or DJ-1.

M Emdadul Haque1, Matthew P Mount, Farzaneh Safarpour, Elizabeth Abdel-Messih, Steve Callaghan, Chantal Mazerolle, Tohru Kitada, Ruth S Slack, Valerie Wallace, Jie Shen, Hymie Anisman, David S Park.   

Abstract

Mutations in the mitochondrial PTEN-induced kinase 1 (Pink1) gene have been linked to Parkinson disease (PD). Recent reports including our own indicated that ectopic Pink1 expression is protective against toxic insult in vitro, suggesting a potential role for endogenous Pink1 in mediating survival. However, the role of endogenous Pink1 in survival, particularly in vivo, is unclear. To address this critical question, we examined whether down-regulation of Pink1 affects dopaminergic neuron loss following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the adult mouse. Two model systems were utilized: virally delivered shRNA-mediated knockdown of Pink1 and germ line-deficient mice. In both instances, loss of Pink1 generated significant sensitivity to damage induced by systemic MPTP treatment. This sensitivity was associated with greater loss of dopaminergic neurons in the Substantia Nigra pars compacta and terminal dopamine fiber density in the striatum region. Importantly, we also show that viral mediated expression of two other recessive PD-linked familial genes, DJ-1 and Parkin, can protect dopaminergic neurons even in the absence of Pink1. This evidence not only provides strong evidence for the role of endogenous Pink1 in neuronal survival, but also supports a role of DJ-1 and Parkin acting parallel or downstream of endogenous Pink1 to mediate survival in a mammalian in vivo context.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22511790      PMCID: PMC3391096          DOI: 10.1074/jbc.M112.346437

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

Review 1.  Recent advances in the genetics of Parkinson's disease.

Authors:  Ian Martin; Valina L Dawson; Ted M Dawson
Journal:  Annu Rev Genomics Hum Genet       Date:  2011       Impact factor: 8.929

Review 2.  MPTP as a mitochondrial neurotoxic model of Parkinson's disease.

Authors:  Serge Przedborski; Kim Tieu; Celine Perier; Miquel Vila
Journal:  J Bioenerg Biomembr       Date:  2004-08       Impact factor: 2.945

Review 3.  The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis.

Authors:  H J Gundersen; P Bagger; T F Bendtsen; S M Evans; L Korbo; N Marcussen; A Møller; K Nielsen; J R Nyengaard; B Pakkenberg
Journal:  APMIS       Date:  1988-10       Impact factor: 3.205

4.  Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1.

Authors:  Matthew S Goldberg; Antonio Pisani; Marian Haburcak; Timothy A Vortherms; Tohru Kitada; Cinzia Costa; Youren Tong; Giuseppina Martella; Anne Tscherter; Andrea Martins; Giorgio Bernardi; Bryan L Roth; Emmanuel N Pothos; Paolo Calabresi; Jie Shen
Journal:  Neuron       Date:  2005-02-17       Impact factor: 17.173

5.  Impaired mitochondrial transport and Parkin-independent degeneration of respiratory chain-deficient dopamine neurons in vivo.

Authors:  Fredrik H Sterky; Seungmin Lee; Rolf Wibom; Lars Olson; Nils-Göran Larsson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-18       Impact factor: 11.205

6.  Parkin-mediated protection of dopaminergic neurons in a chronic MPTP-minipump mouse model of Parkinson disease.

Authors:  Toru Yasuda; Hideki Hayakawa; Tomoko Nihira; Yong-Ri Ren; Yasuto Nakata; Makiko Nagai; Nobutaka Hattori; Koichi Miyake; Masahiko Takada; Takashi Shimada; Yoshikuni Mizuno; Hideki Mochizuki
Journal:  J Neuropathol Exp Neurol       Date:  2011-08       Impact factor: 3.685

7.  Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance.

Authors:  Jeffrey P MacKeigan; Leon O Murphy; John Blenis
Journal:  Nat Cell Biol       Date:  2005-05-01       Impact factor: 28.824

Review 8.  Targeting mitochondrial dysfunction: role for PINK1 and Parkin in mitochondrial quality control.

Authors:  Derek P Narendra; Richard J Youle
Journal:  Antioxid Redox Signal       Date:  2011-03-03       Impact factor: 8.401

9.  Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress.

Authors:  Raymond H Kim; Patrice D Smith; Hossein Aleyasin; Shawn Hayley; Matthew P Mount; Scott Pownall; Andrew Wakeham; Annick J You-Ten; Suneil K Kalia; Patrick Horne; David Westaway; Andres M Lozano; Hymie Anisman; David S Park; Tak W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-22       Impact factor: 11.205

10.  Expression of Sonic hedgehog and its putative role as a precursor cell mitogen in the developing mouse retina.

Authors:  A M Jensen; V A Wallace
Journal:  Development       Date:  1997-01       Impact factor: 6.868

View more
  39 in total

Review 1.  Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.

Authors:  Nicole Exner; Anne Kathrin Lutz; Christian Haass; Konstanze F Winklhofer
Journal:  EMBO J       Date:  2012-06-26       Impact factor: 11.598

Review 2.  PINK1 as a molecular checkpoint in the maintenance of mitochondrial function and integrity.

Authors:  Hyongjong Koh; Jongkyeong Chung
Journal:  Mol Cells       Date:  2012-05-18       Impact factor: 5.034

3.  Comparative analysis of Parkinson's disease-associated genes in mice reveals altered survival and bioenergetics of Parkin-deficient dopamine neurons.

Authors:  Nicolas Giguère; Consiglia Pacelli; Caroline Saumure; Marie-Josée Bourque; Diana Matheoud; Daniel Levesque; Ruth S Slack; David S Park; Louis-Éric Trudeau
Journal:  J Biol Chem       Date:  2018-04-26       Impact factor: 5.157

Review 4.  Gene therapy targeting mitochondrial pathway in Parkinson's disease.

Authors:  Chi-Jing Choong; Hideki Mochizuki
Journal:  J Neural Transm (Vienna)       Date:  2016-09-16       Impact factor: 3.575

5.  Neurotoxin mechanisms and processes relevant to Parkinson's disease: an update.

Authors:  Juan Segura-Aguilar; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2015-01-29       Impact factor: 3.911

6.  The effects of pdr1, djr1.1 and pink1 loss in manganese-induced toxicity and the role of α-synuclein in C. elegans.

Authors:  Julia Bornhorst; Sudipta Chakraborty; Sören Meyer; Hanna Lohren; Sigrid Grosse Brinkhaus; Adam L Knight; Kim A Caldwell; Guy A Caldwell; Uwe Karst; Tanja Schwerdtle; Aaron Bowman; Michael Aschner
Journal:  Metallomics       Date:  2014-01-22       Impact factor: 4.526

Review 7.  Parkinson's disease and enhanced inflammatory response.

Authors:  Iva Stojkovska; Brandon M Wagner; Brad E Morrison
Journal:  Exp Biol Med (Maywood)       Date:  2015-03-13

8.  Long-term oral kinetin does not protect against α-synuclein-induced neurodegeneration in rodent models of Parkinson's disease.

Authors:  Adam L Orr; Florentine U Rutaganira; Daniel de Roulet; Eric J Huang; Nicholas T Hertz; Kevan M Shokat; Ken Nakamura
Journal:  Neurochem Int       Date:  2017-04-20       Impact factor: 3.921

9.  Parkin-knockout mice did not display increased vulnerability to intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

Authors:  Aderbal S Aguiar; Fabrine S M Tristão; Majid Amar; Caroline Chevarin; Laurence Lanfumey; Raymond Mongeau; Olga Corti; Rui D Prediger; Rita Raisman-Vozari
Journal:  Neurotox Res       Date:  2013-04-16       Impact factor: 3.911

Review 10.  Defective autophagy in Parkinson's disease: lessons from genetics.

Authors:  H Zhang; C Duan; H Yang
Journal:  Mol Neurobiol       Date:  2014-07-04       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.